175 related articles for article (PubMed ID: 36538073)
1. Association of computed tomography-based body composition with survival in metastatic renal cancer patient received immunotherapy: a multicenter, retrospective study.
Wang J; Dong P; Qu Y; Xu W; Zhou Z; Ning K; Peng Y; Xiong L; Li Z; Zou X; Liu Z; Li M; He Z; Luo J; Tian X; Zhang H; Guo S; Han H; Zhou F; Yin S; Ye D; Yu C; Zhang Z
Eur Radiol; 2023 May; 33(5):3232-3242. PubMed ID: 36538073
[TBL] [Abstract][Full Text] [Related]
2. Perirenal Fat Thickness Significantly Associated with Prognosis of Metastatic Renal Cell Cancer Patients Receiving Anti-VEGF Therapy.
Ning K; Li Z; Liu H; Tian X; Wang J; Wu Y; Xiong L; Zou X; Peng Y; Zhou Z; Zhou F; Yu C; Luo J; Zhang H; Dong P; Zhang Z
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014894
[TBL] [Abstract][Full Text] [Related]
3. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line Ipilimumab Plus Nivolumab.
McManus HD; Zhang D; Schwartz FR; Wu Y; Infield J; Ho E; Armstrong AJ; George DJ; Kruse D; Gupta RT; Harrison MR
Clin Genitourin Cancer; 2023 Dec; 21(6):e429-e437.e2. PubMed ID: 37271698
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer.
Blanc-Durand P; Campedel L; Mule S; Jegou S; Luciani A; Pigneur F; Itti E
Eur Radiol; 2020 Jun; 30(6):3528-3537. PubMed ID: 32055950
[TBL] [Abstract][Full Text] [Related]
6. Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis.
Vrieling A; Kampman E; Knijnenburg NC; Mulders PF; Sedelaar JPM; Baracos VE; Kiemeney LA
Eur Urol Focus; 2018 Apr; 4(3):420-434. PubMed ID: 28753824
[TBL] [Abstract][Full Text] [Related]
7. The Association of Body Composition Parameters Measured by Computed Tomography with Cancer Stage, Prognosis, and Survival in Patients with Renal Cell Carcinoma.
Gur Ozcan SG; Barali D; Erkan A
Curr Med Imaging; 2024; 20(1):e15734056301569. PubMed ID: 38544394
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer - A multicenter population-based cohort study.
Maurits JSF; Sedelaar JPM; Mulders PFA; Aben KKH; Kiemeney LALM; Vrieling A
Clin Nutr; 2022 Jan; 41(1):131-143. PubMed ID: 34872047
[TBL] [Abstract][Full Text] [Related]
9. Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy.
Chaunzwa TL; Qian JM; Li Q; Ricciuti B; Nuernberg L; Johnson JW; Weiss J; Zhang Z; MacKay J; Kagiampakis I; Bikiel D; Di Federico A; Alessi JV; Mak RH; Jacob E; Awad MM; Aerts HJWL
JAMA Oncol; 2024 May; ():. PubMed ID: 38780929
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Utility of Parameters Derived From Pretreatment Dual-Layer Spectral-Detector CT in Patients With Metastatic Renal Cell Carcinoma.
Drljevic-Nielsen A; Donskov F; Mains JR; Andersen MB; Thorup K; Thygesen J; Rasmussen F
AJR Am J Roentgenol; 2022 May; 218(5):867-876. PubMed ID: 34910540
[No Abstract] [Full Text] [Related]
11. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
Sanchez A; Furberg H; Kuo F; Vuong L; Ged Y; Patil S; Ostrovnaya I; Petruzella S; Reising A; Patel P; Mano R; Coleman J; Russo P; Liu CH; Dannenberg AJ; Chan TA; Motzer R; Voss MH; Hakimi AA
Lancet Oncol; 2020 Feb; 21(2):283-293. PubMed ID: 31870811
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of components of body composition in patients treated with targeted therapy for advanced renal cell carcinoma: a retrospective case series.
Gu W; Zhu Y; Wang H; Zhang H; Shi G; Liu X; Ye D
PLoS One; 2015; 10(2):e0118022. PubMed ID: 25668688
[TBL] [Abstract][Full Text] [Related]
13. Low subcutaneous adipose tissue and myosteatosis are prognostic factors after allogeneic hematopoietic stem cell transplantation.
Barajas Ordonez F; Zeller Y; Wolleschak D; Hinnerichs M; Rodríguez-Feria P; Mougiakakos D; Aghayev A; Kardas H; Mikusko M; Borggrefe J; Surov A
Clin Nutr ESPEN; 2024 Jun; 61():274-280. PubMed ID: 38777443
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment subcutaneous adipose tissue predicts the outcomes of patients with head and neck cancer receiving definitive radiation and chemoradiation in Taiwan.
Pai PC; Chuang CC; Chuang WC; Tsang NM; Tseng CK; Chen KH; Yen TC; Lin CY; Chang KP; Lei KF
Cancer Med; 2018 May; 7(5):1630-1641. PubMed ID: 29608254
[TBL] [Abstract][Full Text] [Related]
15. CT-defined body composition as a prognostic factor in multiple myeloma.
Surov A; Benkert F; Pönisch W; Meyer HJ
Hematology; 2023 Dec; 28(1):2191075. PubMed ID: 36946869
[TBL] [Abstract][Full Text] [Related]
16. Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma.
Aslan V; Kılıç ACK; Sütcüoğlu O; Eraslan E; Bayrak A; Öksüzoğlu B; Tahtacı G; Özdemir N; Üner A; Günel N; Özet A; Yazıcı O
Urol Oncol; 2022 Nov; 40(11):494.e1-494.e10. PubMed ID: 36137881
[TBL] [Abstract][Full Text] [Related]
17. Body Composition, Coronary Microvascular Dysfunction, and Future Risk of Cardiovascular Events Including Heart Failure.
Souza ACDAH; Rosenthal MH; Moura FA; Divakaran S; Osborne MT; Hainer J; Dorbala S; Blankstein R; Di Carli MF; Taqueti VR
JACC Cardiovasc Imaging; 2024 Feb; 17(2):179-191. PubMed ID: 37768241
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Pretreatment Overweight/Obesity and Adipose Tissue Distribution in Resectable Gastric Cancer: A Retrospective Cohort Study.
Gu L; Zhang Y; Hong J; Xu B; Yang L; Yan K; Zhang J; Chen P; Zheng J; Lin J
Front Oncol; 2021; 11():680190. PubMed ID: 34249721
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies.
Antoun S; Lanoy E; Iacovelli R; Albiges-Sauvin L; Loriot Y; Merad-Taoufik M; Fizazi K; di Palma M; Baracos VE; Escudier B
Cancer; 2013 Sep; 119(18):3377-84. PubMed ID: 23801109
[TBL] [Abstract][Full Text] [Related]
20. Association of body composition with survival and inflammatory responses in patients with non-metastatic nasopharyngeal cancer.
He WZ; Jiang C; Liu LL; Yin CX; Rong YM; Hu WM; Yang L; Wang L; Jin YN; Lin XP; Liu SS; Huang JS; He SS; Liang YQ; Qiu HJ; Zhang B; Fan W; Guo GF; Yang QX; Xia LP
Oral Oncol; 2020 Sep; 108():104771. PubMed ID: 32485608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]